SCHEMBL8094713

SCHEMBL8094713

CC(CSSCC(C)C(=O)N1CCCC1C(=O)O)C(=O)N1CCCC1C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ACE P12821 6/20 0.70
REN P00797 4/20 0.70
KDM4E B2RXH2 1/20 0.70
F2 P00734 1/20 0.70
LMNA P02545 1/20 0.70
LTA4H P09960 1/20 0.70
MAPT P10636 1/20 0.70
PEPD P12955 1/20 0.70
ALOX15 P16050 1/20 0.70
PTGS1 P23219 1/20 0.70
HTR2A P28223 1/20 0.70
PTGS2 P35354 1/20 0.70
HRH1 P35367 1/20 0.70
THPO P40225 1/20 0.70
PMP22 Q01453 1/20 0.70
HSD17B10 Q99714 1/20 0.70
ACE2 Q9BYF1 1/20 0.70
RAB9A P51151 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2443468 1.00 ACE (0.70) ACERENKDM4EF2LMNA
SCHEMBL11212417 1.00 ACE (0.70) ACERENKDM4EF2LMNA
SCHEMBL6783588 1.00 ACE (0.70) ACERENKDM4EF2LMNA
SCHEMBL683117 1.00 ACE (0.70) ACERENKDM4EF2LMNA
SCHEMBL5556548 1.00 ACE (0.70) ACERENKDM4EF2LMNA
SCHEMBL18158948 0.96 ACE (0.65) ACERENKDM4EF2LMNA
SCHEMBL18158950 0.96 ACE (0.65) ACERENKDM4EF2LMNA
SCHEMBL10935359 0.92 ACE (0.60) ACERENKDM4EF2LMNA
SCHEMBL4385014 0.91 ACE (0.67) ACERENKDM4EF2LMNA
SCHEMBL4385017 0.91 ACE (0.67) ACERENKDM4EF2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6103910-A FOR TREATMENT OF DISEASES ASSOCIATED WITH AMYLOIDOSIS, SUCH AS ALZHEIMER'S DISEASE, DIABETES MELLITUS, FAMILIAL AMYLOID POLYNEUROPATHY, SCRAPIE, AND KREUZFELD-JACOB DISEASE HOFFMANN-LA ROCHE INC. (US) 2000-08-15 US disclosed